Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 25.02% is 36% above its 5-year average of 18.42%, near the high end of its 5-year range (8.35%–28.44%).
2.66% above its 12-month average of 24.37%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 24.22%.
NET PROFIT MARGIN
25.02%
NET PROFIT MARGIN AVG TTM
24.37%
NET PROFIT MARGIN AVG 3Y
20.74%
NET PROFIT MARGIN AVG 5Y
18.42%
NET PROFIT MARGIN AVG 10Y
17.17%
NET PROFIT MARGIN AVG 15Y
13.83%
NET PROFIT MARGIN AVG 20Y
11.22%
CURRENT VS TTM AVG
+2.66%
CURRENT VS 3Y AVG
+20.64%
CURRENT VS 5Y AVG
+35.85%
CURRENT VS 10Y AVG
+45.72%
CURRENT VS 15Y AVG
+80.94%
CURRENT VS 20Y AVG
+123.07%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+9723.08%
vs the sector median at left
LeMaitre Vascular, Inc.
Market Cap
$1.81B
Net Profit Margin
25.02%
TTM Avg
24.37%
3Y Avg
20.74%
5Y Avg
18.42%
Market Cap
$1.81B
Net Profit Margin
-155.59%
TTM Avg
-141.87%
3Y Avg
-98.38%
5Y Avg
-69.99%
Market Cap
$1.81B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.83B
Net Profit Margin
-6.93%
TTM Avg
-10.04%
3Y Avg
-34.65%
5Y Avg
-50.14%
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.84B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-32.12%
5Y Avg
-45.68%
Market Cap
$1.77B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.85B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$1.75B
Net Profit Margin
-2.63%
TTM Avg
-3.88%
3Y Avg
-2.58%
5Y Avg
-3.29%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.81B | 25.02% | 24.37% | 20.74% | 18.42% |
| Xencor, Inc. (XNCR)vs › | $1.81B | -155.59% | -141.87% | -98.38% | -69.99% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -20.02% | -19.08% | -29.38% | -13.21% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -6.93% | -10.04% | -34.65% | -50.14% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | -32.12% | -45.68% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -636.99% | -743.17% | -743.17% | -743.17% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | -2.63% | -3.88% | -2.58% | -3.29% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -59.87% | 5.85% | -31.86% | -479.70% |
Operating Margin
29.5%
Net Profit Margin
25.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 24.22% |
| 2026-03-31 | 23.56% |
| 2025-12-31 | 24.18% |
| 2025-09-30 | 28.44% |
| 2025-06-30 | 21.45% |
| 2025-03-31 | 18.39% |
| 2024-12-31 | 20.07% |
| 2024-09-30 | 20.32% |
| 2024-06-30 | 21.17% |
| 2024-03-31 | 18.49% |
| 2023-12-31 | 17.32% |
| 2023-09-30 | 15.82% |
| 2023-06-30 | 16.16% |
| 2023-03-31 | 12.83% |
| 2022-12-31 | 13.74% |
| 2022-09-30 | 13.98% |
| 2022-06-30 | 8.35% |
| 2022-03-31 | 15.26% |
| 2021-12-31 | 15.63% |
| 2021-09-30 | 16.95% |
| 2021-06-30 | 20.41% |
| 2021-03-31 | 16.52% |
| 2020-12-31 | 18.73% |
| 2020-09-30 | 20.63% |
| 2020-06-30 | 14.08% |
| 2020-03-31 | 10.39% |
| 2019-12-31 | 15.29% |
| 2019-09-30 | 17.81% |
| 2019-06-30 | 15.68% |
| 2019-03-31 | 12.34% |
| 2018-12-31 | 21.22% |
| 2018-09-30 | 17.85% |
| 2018-06-30 | 32.39% |
| 2018-03-31 | 14.82% |
| 2017-12-31 | 16.38% |
| 2017-09-30 | 20.31% |
| 2017-06-30 | 17.99% |
| 2017-03-31 | 13.34% |
| 2016-12-31 | 11.15% |
| 2016-09-30 | 13.91% |
| 2016-06-30 | 11.60% |
| 2016-03-31 | 10.69% |
| 2015-12-31 | 12.35% |
| 2015-09-30 | 11.00% |
| 2015-06-30 | 8.88% |
| 2015-03-31 | 7.23% |
| 2014-12-31 | 10.26% |
| 2014-09-30 | 5.34% |
| 2014-06-30 | 7.00% |
| 2014-03-31 | -1.24% |
| 2013-12-31 | 4.16% |
| 2013-09-30 | 5.10% |
| 2013-06-30 | 5.57% |
| 2013-03-31 | 5.50% |
| 2012-12-31 | 4.72% |
| 2012-09-30 | 4.86% |
| 2012-06-30 | 5.74% |
| 2012-03-31 | 2.77% |
| 2011-12-31 | 2.58% |
| 2011-09-30 | 8.34% |
| 2011-06-30 | 3.43% |
| 2011-03-31 | 0.44% |
| 2010-12-31 | 13.61% |
| 2010-09-30 | 11.11% |
| 2010-06-30 | 10.67% |
| 2010-03-31 | 7.39% |
| 2009-12-31 | 9.34% |
| 2009-09-30 | 9.63% |
| 2009-06-30 | 7.32% |
| 2009-03-31 | -16.58% |
| 2008-12-31 | 2.58% |
| 2008-09-30 | -1.13% |
| 2008-06-30 | -7.27% |
| 2008-03-31 | -21.64% |
| 2007-12-31 | -10.61% |
| 2007-09-30 | -13.35% |
| 2007-06-30 | 2.20% |
| 2007-03-31 | -6.36% |
| 2006-12-31 | -7.70% |
| 2006-09-30 | 2.60% |
| 2006-06-30 | -12.44% |
| 2006-03-31 | 4.32% |
| 2005-12-31 | 0.52% |
| 2005-09-30 | -0.54% |
| 2005-06-30 | 0.07% |
| 2005-03-31 | 0.68% |
| 2004-12-31 | 3.53% |
| 2004-09-30 | 3.54% |
| 2004-06-30 | 3.54% |
| 2004-03-31 | 3.54% |
